HYDREA 830 HYDREA 830 Pill - pink & turquoise capsule/oblong, 22mm
Generic Name: hydroxyurea
Pill with imprint HYDREA 830 HYDREA 830 is Pink & Turquoise, Capsule/Oblong and has been identified as Hydrea 500 mg. It is supplied by Bristol-Myers Squibb.
Hydrea is used in the treatment of Chronic Myelogenous Leukemia; Head and Neck Cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydrea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HYDREA 830 HYDREA 830
Hydrea
- Generic Name
- hydroxyurea
- Imprint
- HYDREA 830 HYDREA 830
- Strength
- 500 mg
- Color
- Pink & Turquoise
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-0830
- Inactive Ingredients
-
citric acid monohydrate,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Red No. 40,
D&C Red No. 28,
gelatin,
magnesium stearate,
sodium phosphate,
titanium dioxide
Note: Inactive ingredients may vary.
More about Hydrea (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Droxia, Siklos, Mylocel, Xromi
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
